does berberine act like a glp 1 as multi-target therapeutic agent for obesity: from pharmacological mechanisms to clinical evidence | European Journal of Medical Research Berberine: The Truth Behind “Nature's

Kwok et al

Because venoms are so adept at homing in on vulnerable parts of the human bodydesigned by nature to find a target while evading destruction by the bodys natural defensesthey are an ideal template for drug development, Takacs explains

Ultimately, its best to consult a dietitian or healthcare provider when deciding which form is best for you

In fact, as outlined above, HF is even more prevalent amongst people with obesity than amongst those with type 2 diabetes, and the consequences of excess body weight (i.e., adipose tissue) most likely play direct and indirect key roles in the development of HF

So stay tuned